phosphatidylinositol-5-phosphate and Leukemia--Myeloid--Acute

phosphatidylinositol-5-phosphate has been researched along with Leukemia--Myeloid--Acute* in 2 studies

Reviews

1 review(s) available for phosphatidylinositol-5-phosphate and Leukemia--Myeloid--Acute

ArticleYear
PIP4K and the role of nuclear phosphoinositides in tumour suppression.
    Biochimica et biophysica acta, 2015, Volume: 1851, Issue:6

    Phosphatidylinositol-5-phosphate (PtdIns5P)-4-kinases (PIP4Ks) are stress-regulated lipid kinases that phosphorylate PtdIns5P to generate PtdIns(4,5)P₂. There are three isoforms of PIP4Ks: PIP4K2A, 2B and 2C, which localise to different subcellular compartments with the PIP4K2B isoform being localised predominantly in the nucleus. Suppression of PIP4K expression selectively prevents tumour cell growth in vitro and prevents tumour development in mice that have lost the tumour suppressor p53. p53 is lost or mutated in over 70% of all human tumours. These studies suggest that inhibition of PIP4K signalling constitutes a novel anti-cancer therapeutic target. In this review we will discuss the role of PIP4K in tumour suppression and speculate on how PIP4K modulates nuclear phosphoinositides (PPIns) and how this might impact on nuclear functions to regulate cell growth. This article is part of a Special Issue entitled Phosphoinositides.

    Topics: 1-Phosphatidylinositol 4-Kinase; Animals; Antineoplastic Agents; Cell Nucleus; Cytoplasm; Gene Expression Regulation, Leukemic; Humans; Isoenzymes; Leukemia, Myeloid, Acute; Mice; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Protein Kinase Inhibitors; Signal Transduction; Tumor Suppressor Protein p53

2015

Other Studies

1 other study(ies) available for phosphatidylinositol-5-phosphate and Leukemia--Myeloid--Acute

ArticleYear
A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival.
    Oncogene, 2015, Mar-05, Volume: 34, Issue:10

    Given the importance of deregulated phosphoinositide (PI) signaling in leukemic hematopoiesis, genes coding for proteins that regulate PI metabolism may have significant and as yet unappreciated roles in leukemia. We performed a targeted knockdown (KD) screen of PI modulator genes in human acute myeloid leukemia (AML) cells and identified candidates required to sustain proliferation or prevent apoptosis. One of these, the lipid kinase phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP4K2A) regulates cellular levels of phosphatidylinositol-5-phosphate (PtsIns5P) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P₂). We found PIP4K2A to be essential for the clonogenic and leukemia-initiating potential of human AML cells, and for the clonogenic potential of murine MLL-AF9 AML cells. Importantly, PIP4K2A is also required for the clonogenic potential of primary human AML cells. Its KD results in accumulation of the cyclin-dependent kinase inhibitors CDKN1A and CDKN1B, G₁ cell cycle arrest and apoptosis. Both CDKN1A accumulation and apoptosis were partially dependent on activation of the mTOR pathway. Critically, however, PIP4K2A KD in normal hematopoietic stem and progenitor cells, both murine and human, did not adversely impact either clonogenic or multilineage differentiation potential, indicating a selective dependency that we suggest may be the consequence of the regulation of different transcriptional programs in normal versus malignant cells. Thus, PIP4K2A is a novel candidate therapeutic target in myeloid malignancy.

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cluster Analysis; Enzyme Activation; Gene Expression Profiling; Gene Knockdown Techniques; Humans; Intracellular Space; Leukemia, Myeloid, Acute; Mice; Mice, Transgenic; Neoplastic Stem Cells; Phosphatidylinositol Phosphates; Phosphatidylinositols; Phosphotransferases (Alcohol Group Acceptor); TOR Serine-Threonine Kinases; Tumor Stem Cell Assay

2015